维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="BURMESTER JK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin- induced muscle damage显示文摘	Wilke RA Moore JH Burmester JK	2005	Pharrnacogenet Genomics2005，15，6：	1
2	Gene therapy for cancer treatment:past,present and future显示文摘	Cross D Burmester JK	2006	Clin Med Res2006，4，3：	1
3	Isolation and expression of rat I,25-dihydroxyvitamin D3 receptor cDNA显示文摘	Burmester JK Maeda N DeLuca HF	1988	Proc Natl Acad Sci USA1988，85，4：	1
4	Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype显示文摘	Hillman MA Wilke RA Caldwell MD Berg RL Glurich I Burmester JK	2004	Pharmacogenetics2004，14，：	1
5	Medical applications of transforming growth factor-beta显示文摘	Flanders KC Burmester JK	2003	Clin Med Res2003，1，1：	1
6	Intraocular pres- sure response to topical 13 - blockers associated with an ADRB2 sin- gle - nucleotide polymorphism 显示文摘	McCarty CA Burmester JK Mukesh BN	2008	Arch Ophthalmol2008，126，：	1
7	Intraocular pressure response to topical beta-blockers associated with an ADRB2single-nucleotide polymorphism显示文摘	Mc Carty CA Burmester JK Mukesh BN	2008	Arch Ophthalmol2008，126，7：	1
8	Medical applications of Transforming Growth Factor-beta 显示文摘	Flanders KC Burmester JK	2003	Clin Med Res2003，1，1：	1
9	Gene Therapy for Cancer Treatment:Past,Present and Future显示文摘	Cross D Burmester JK	2006	Clin Med Res2006，4，3：	1
10	Gene therapy for cancer treatment : past, present and future显示文摘	Cross D Burmester JK	2006	Clin Med Res2006，4，3：	1
11	A randomized controlled trial of genotype-based Coumadin initiation显示文摘	Burmester JK Berg RL Yale SH	2011	Genet Med2011，13，6：	1
12	Medical applications of transforming growth factor-beta显示文摘	Flanders KC Burmester JK	2003	Clin Med Res2003，1，1：	1
13	Binding affinity of transforming growth factor-beta for its type Ⅱ receptor is determined by the Cterminal region of the molecule 显示文摘	Qian SW Burmester JK Tsang ML etal	1996	J Biol Chem1996，271，30：	1
14	Gene therapy for cancer treatment:past,present and future显示文摘	Gross D Burmester JK	2006	Clin Med Res2006，4，：	1
15	Gene therapy for cancer treatment:past,present and future显示文摘	Cross D Burmester JK	2006	Clin Med Res2006，4，3：	1
16	Absence of novelCYP4F2 and VKOHC1 coding region DNA variants in patientsrequiring high warfarin doses显示文摘	Burmester JK Bei^ RL Glurich I et ai	2011	Clin Med Res2011，9，：	1
17	Gene therapy for cancer treatment:past,present and future显示文摘	Cross D Burmester JK	2006	Clin Med Res2006，4，3：	1
18	Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Re-quirements?显示文摘	Glurich I Berg RL Burmester JK	2013	Clin Med Res2013，11，2：	1
19	A randomized controlled trial of genotype-based Coumadin initiation显示文摘	Burmester JK Berg RL Yale SH		0，，06：	1
20	Medical applications of transforming growth factor-beta 显示文摘	Flanders KC Burmester JK	2003	Clin Med Res2003，1，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示